Stay updated on Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial
Sign up to get notified when there's something new on the Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial page.

Latest updates to the Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. No visible changes to study content or details.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedLocations are consolidated under a single Locations heading listing US states and Canadian provinces. The HHS Vulnerability Disclosure entry was removed and the revision version updated from v3.3.2 to v3.3.3.SummaryDifference2%

- Check53 days agoChange DetectedFooter now shows Revision: v3.3.2, replacing the previous v3.3.1.SummaryDifference0.0%

- Check60 days agoChange DetectedPublications section now notes that PubMed listings are automatically filled and may not all pertain to the study, and the Revision tag was updated to v3.3.1. No substantive study details were changed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedThe government funding notice banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check81 days agoChange DetectedThe updated pages appear to reflect minor formatting changes with no change to core content or study results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial page.